Table 2: Differences in medication discontinuation among groups and subgroups
VariableNo. of medication discontinuations, mean ± SDp value for difference
MERA intervention group3.1 ± 2.6< 0.001*
Non-MERA comparison group0.9 ± 1.5
Within intervention group
Main inclusion criterion0.6†
Age > 80 yr3.0 ± 3.1
Metastatic cancer2.8 ± 1.7
End-stage organ failure3.6 ± 2.9
Role of palliative care0.4†
    Followed by palliative care specialist4.0 ± 2.8
    Never followed by palliative care specialist2.8 ± 2.3
    Palliative care consultation suggested by MERA team     but refused by admitting team or patient2.8 ± 3.3

Note: MERA = Medication Rationalization, SD = standard deviation.

*Mann-Whitney U test.

†Kruskal-Wallis ANOVA.